{"id":"https://openalex.org/W2012011634","doi":"https://doi.org/10.1111/j.1527-3458.1997.tb00324.x","title":"A Review of the Preclinical Development of Zaleplon, a Novel Non\u2010Benzodiazepine Hypnotic for the Treatment of Insomnia","display_name":"A Review of the Preclinical Development of Zaleplon, a Novel Non\u2010Benzodiazepine Hypnotic for the Treatment of Insomnia","publication_year":1997,"publication_date":"1997-09-01","ids":{"openalex":"https://openalex.org/W2012011634","doi":"https://doi.org/10.1111/j.1527-3458.1997.tb00324.x","mag":"2012011634"},"language":"en","primary_location":{"id":"doi:10.1111/j.1527-3458.1997.tb00324.x","doi":"https://doi.org/10.1111/j.1527-3458.1997.tb00324.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1527-3458.1997.tb00324.x","pdf_url":null,"source":{"id":"https://openalex.org/S165828461","display_name":"CNS Drug Reviews","issn_l":"1080-563X","issn":["1080-563X","1527-3458"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drug Reviews","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112018073","display_name":"B. Beer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Beer","raw_affiliation_strings":["Dr. Beer's present address is DOV Pharmaceuticals, Inc., 400 Kelby Street, Fort Lee, NJ 07024, USA","Wyeth-Ayerst Research, Central Nervous System Division, Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. Beer's present address is DOV Pharmaceuticals, Inc., 400 Kelby Street, Fort Lee, NJ 07024, USA","institution_ids":[]},{"raw_affiliation_string":"Wyeth-Ayerst Research, Central Nervous System Division, Princeton, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054066465","display_name":"Donald E. Clody","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. E. Clody","raw_affiliation_strings":["Dr. Clody's present address is Biometric Research Institute International, Inc., 1300 N. 17th Street, Arlington, VA 22209, USA","Wyeth-Ayerst Research, Central Nervous System Division, Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. Clody's present address is Biometric Research Institute International, Inc., 1300 N. 17th Street, Arlington, VA 22209, USA","institution_ids":[]},{"raw_affiliation_string":"Wyeth-Ayerst Research, Central Nervous System Division, Princeton, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075160181","display_name":"Richard M. Mangano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Mangano","raw_affiliation_strings":["Wyeth-Ayerst Research, Central Nervous System Division, Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wyeth-Ayerst Research, Central Nervous System Division, Princeton, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011423408","display_name":"M. Levner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Levner","raw_affiliation_strings":["Wyeth-Ayerst Research, Central Nervous System Division, Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wyeth-Ayerst Research, Central Nervous System Division, Princeton, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109557158","display_name":"Peter Eduard Mayer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Mayer","raw_affiliation_strings":["Wyeth-Ayerst Research, Central Nervous System Division, Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wyeth-Ayerst Research, Central Nervous System Division, Princeton, NJ, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021028666","display_name":"James E. Barrett","orcid":"https://orcid.org/0000-0002-4328-7596","observed_orcids":["https://orcid.org/0000-0002-4328-7596"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"J. E. Barrett","raw_affiliation_strings":["Wyeth-Ayerst Research, Central Nervous System Division, Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wyeth-Ayerst Research, Central Nervous System Division, Princeton, NJ, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5021028666"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.3697,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.96545072,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"3","issue":"3","first_page":"207","last_page":"224"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10316","display_name":"Sleep and related disorders","score":0.9038000106811523,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10316","display_name":"Sleep and related disorders","score":0.9038000106811523,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.04540000110864639,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10985","display_name":"Sleep and Wakefulness Research","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/zaleplon","display_name":"zaleplon","score":0.9980000257492065},{"id":"https://openalex.org/keywords/non-benzodiazepine-hypnotics","display_name":"non-benzodiazepine hypnotics","score":0.9649999737739563},{"id":"https://openalex.org/keywords/insomnia-treatment","display_name":"insomnia treatment","score":0.828000009059906},{"id":"https://openalex.org/keywords/gabaa-benzodiazepine-receptor","display_name":"GABA-benzodiazepine receptor complex","score":0.9639999866485596},{"id":"https://openalex.org/keywords/discriminative-stimuli","display_name":"discriminative stimulus","score":0.7379999756813049},{"id":"https://openalex.org/keywords/drug-substitution","display_name":"drug substitution","score":0.3409999907016754},{"id":"https://openalex.org/keywords/triazolam","display_name":"triazolam","score":0.6039999723434448},{"id":"https://openalex.org/keywords/zolpidem","display_name":"zolpidem","score":0.8619999885559082},{"id":"https://openalex.org/keywords/alpidem","display_name":"alpidem","score":0.7950000166893005},{"id":"https://openalex.org/keywords/bretazenil","display_name":"bretazenil","score":0.7170000076293945},{"id":"https://openalex.org/keywords/cl-218-872","display_name":"CL 218,872","score":0.8930000066757202},{"id":"https://openalex.org/keywords/anticonvulsant-activity","display_name":"anticonvulsant activity","score":0.8109999895095825},{"id":"https://openalex.org/keywords/sustained-attention","display_name":"sustained attention","score":0.6539999842643738}],"concepts":[{"id":"https://openalex.org/C2777123777","wikidata":"https://www.wikidata.org/wiki/Q218842","display_name":"Zolpidem","level":3,"score":0.878065824508667},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.7955707311630249},{"id":"https://openalex.org/C2778409475","wikidata":"https://www.wikidata.org/wiki/Q421920","display_name":"Flumazenil","level":4,"score":0.7679415941238403},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6899102926254272},{"id":"https://openalex.org/C2779738154","wikidata":"https://www.wikidata.org/wiki/Q412143","display_name":"Triazolam","level":4,"score":0.6466532945632935},{"id":"https://openalex.org/C2780930544","wikidata":"https://www.wikidata.org/wiki/Q62962","display_name":"Hypnotic","level":2,"score":0.5076926946640015},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.5003676414489746},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.49915027618408203},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.48756951093673706},{"id":"https://openalex.org/C2777196872","wikidata":"https://www.wikidata.org/wiki/Q319877","display_name":"Alprazolam","level":3,"score":0.4446799159049988},{"id":"https://openalex.org/C2781442855","wikidata":"https://www.wikidata.org/wiki/Q62947","display_name":"Flunitrazepam","level":4,"score":0.43153834342956543},{"id":"https://openalex.org/C2776156762","wikidata":"https://www.wikidata.org/wiki/Q418998","display_name":"Flurazepam","level":4,"score":0.42592233419418335},{"id":"https://openalex.org/C2777602617","wikidata":"https://www.wikidata.org/wiki/Q847705","display_name":"Sedative","level":2,"score":0.4170398414134979},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2928253412246704},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2071443498134613},{"id":"https://openalex.org/C2781210498","wikidata":"https://www.wikidata.org/wiki/Q1869874","display_name":"Insomnia","level":2,"score":0.16102999448776245},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.15684917569160461},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.05647385120391846},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1111/j.1527-3458.1997.tb00324.x","doi":"https://doi.org/10.1111/j.1527-3458.1997.tb00324.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1527-3458.1997.tb00324.x","pdf_url":null,"source":{"id":"https://openalex.org/S165828461","display_name":"CNS Drug Reviews","issn_l":"1080-563X","issn":["1080-563X","1527-3458"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drug Reviews","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1122852452","https://openalex.org/W1597869519","https://openalex.org/W1678749935","https://openalex.org/W1968637943","https://openalex.org/W1988890863","https://openalex.org/W1994785056","https://openalex.org/W2001523104","https://openalex.org/W2002667183","https://openalex.org/W2007065735","https://openalex.org/W2010441130","https://openalex.org/W2020233726","https://openalex.org/W2022466839","https://openalex.org/W2027127607","https://openalex.org/W2028718926","https://openalex.org/W2037410995","https://openalex.org/W2038299708","https://openalex.org/W2062647664","https://openalex.org/W2075672970","https://openalex.org/W2075723143","https://openalex.org/W2084394804","https://openalex.org/W2088959265","https://openalex.org/W2103651118","https://openalex.org/W2106915249","https://openalex.org/W2108809108","https://openalex.org/W2196718264","https://openalex.org/W2410393979","https://openalex.org/W4252196055","https://openalex.org/W4323517653"],"related_works":["https://openalex.org/W2123542917","https://openalex.org/W3190899331","https://openalex.org/W1965624809","https://openalex.org/W2006992821","https://openalex.org/W1998515862","https://openalex.org/W2017243517","https://openalex.org/W2036670780","https://openalex.org/W2054366367","https://openalex.org/W2055174719","https://openalex.org/W1991208187"],"abstract_inverted_index":{"SUMMARY":[0],"Zaleplon":[1,22,96],"(N\u2010[3\u2010(3\u2010cyanopyrazolo[l,5\u2010a]pyrimidin\u20107\u2010y":[2],"l)phenyl)]\u2010N\u2010ethylacetamide)":[3],"is":[4,273],"a":[5,117,127,139,264,268],"non\u2010benzodiazepine":[6,271],"sedative\u2010hypnotic":[7,76,270],"with":[8,13,29,257],"benzodiazepine\u2010like":[9],"sedative":[10],"effects,":[11,85],"but":[12,241],"less":[14],"apparent":[15],"liability":[16],"for":[17,170,279],"accompanying":[18],"undesirable":[19],"side":[20],"effects.":[21],"displaces":[23],"[3H]flunitrazepam":[24],"from":[25,245],"rat":[26],"cortical":[27],"membranes":[28],"an":[30],"IC50":[31],"value":[32],"of":[33,74,225,254,267,282],"200":[34],"nM":[35],"and":[36,66,81,104,106,138,159,183,198,248],"enhances":[37],"t\u2010butylbicyclophosphorothionate":[38],"[35S]TBPS":[39],"binding":[40],"by":[41,47,90,112],"73%,":[42],"suggesting":[43],"pharmacological":[44],"activity":[45],"mediated":[46],"the":[48,91,135,150,160,176,189,199,223,237,280],"GABAA":[49],"benzodiazepine":[50,92,151,190,238,247,250],"receptor":[51,93,239],"complex.":[52],"In":[53],"various":[54],"preclinical":[55],"procedures":[56],"such":[57,78],"as":[58,79,116,243],"motor":[59],"activity,":[60,65,255],"muscle":[61],"relaxation,":[62],"EEG,":[63],"anticonvulsant":[64],"vigilance,":[67],"zaleplon":[68,125,171,226],"produced":[69],"effects":[70,108,224],"similar":[71,228],"to":[72,134,147,157,165,180,186,195,206,232],"those":[73],"other":[75,233],"compounds":[77,234],"triazolam":[80],"flurazepam;":[82],"furthermore,":[83],"these":[84,107],"when":[86],"evaluated,":[87],"were":[88,109],"reversed":[89],"antagonist":[94],"flumazenil.":[95,113],"increased":[97],"punished":[98],"(conflict)":[99],"responding":[100,132,215],"in":[101,120,130,142,172,212,216,229,260,275],"squirrel":[102],"monkeys":[103],"rats":[105,121],"also":[110],"antagonized":[111],"When":[114],"established":[115],"discriminative":[118],"stimulus":[119],"at":[122,236],"3.0mg/kg":[123],"i.p.,":[124],"showed":[126],"dose\u2010related":[128],"increase":[129],"drug\u2010appropriate":[131,214],"up":[133],"training":[136],"dose":[137],"correlated":[140],"decrease":[141],"response":[143],"rate.":[144],"Triazolam":[145],"(0.1":[146],"1.0":[148],"mg/kg),":[149,188],"partial":[152,191],"agonist":[153,192],"Ro":[154],"17\u20101812":[155],"(0.3":[156],"3.0mg/kg),":[158],"triazolopyridine":[161],"CL":[162,203],"218,872":[163],"(1.0":[164],"3.0":[166],"mg/kg)":[167,182,197,208],"substituted":[168],"consistently":[169],"all":[173,217],"rats,":[174],"whereas":[175],"imidazo\u2010pyridines":[177],"zolpidem":[178],"(3.0":[179],"10":[181,196],"alpidem":[184],"(10":[185,205],"30":[187],"bretazenil":[193],"(0.03":[194],"novel":[200],"putative":[201],"anxio\u2010lytic":[202],"273,547":[204],"56":[207],"did":[209],"not":[210],"result":[211],"consistent":[213],"rats.":[218],"These":[219],"results":[220],"suggest":[221],"that":[222,272],"are":[227],"many":[230],"respects":[231],"acting":[235],"complex":[240],"differ":[242],"well":[244],"both":[246],"non\u2010":[249],"drugs.":[251],"This":[252],"profile":[253,266],"coupled":[256],"additional":[258],"information":[259],"ancillary":[261],"procedures,":[262],"yields":[263],"pre\u2010clinical":[265],"short\u2010acting":[269],"currently":[274],"Phase":[276],"III":[277],"development":[278],"treatment":[281],"sleep":[283],"disturbances.":[284]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}